A prominent health think tank has issued a strong call for the Government to establish a comprehensive national plan for the supervision of pharmacists with prescribing powers operating within community settings. The Centre for Health and the Public Interest (CHPI) has warned that without such a strategy, there could be significant risks to patient safety and the effective integration of these expanded roles into the NHS.
Pharmacists have been able to train as independent prescribers since 2006, a move regulated by the General Pharmaceutical Council (GPhC). More recently, NHS England has committed to funding the training of thousands more pharmacists to become independent prescribers, with the aim of alleviating pressure on GP services and improving patient access to medication and advice. This expansion is seen as a crucial step in modernising primary care.
However, the CHPI report highlights a critical gap: the absence of a consistent, national model for the clinical supervision of these prescribing pharmacists. While the GPhC sets standards for training and ongoing professional development, the think tank argues that the practical implementation of robust supervision varies widely, potentially leaving patients vulnerable and pharmacists without adequate support.
The report suggests that the current situation could lead to a 'postcode lottery' in terms of patient safety and professional oversight. It recommends several key actions for the Government, including the development of a national framework for supervision, the creation of a national register of approved supervisors, and a thorough review of the GPhC's standards for supervision to ensure they are fit for purpose in the context of a rapidly expanding prescribing workforce.
This intervention comes at a time when the NHS is grappling with unprecedented demand and workforce challenges. While empowering pharmacists to prescribe is widely supported as a means to improve efficiency and access, the CHPI's findings underscore the importance of ensuring that such advancements are underpinned by robust governance and safety protocols. The Department of Health and Social Care is now faced with the task of considering these recommendations as it continues to evolve its strategy for primary care.
The CHPI's recommendations are likely to prompt a response from both the Government and professional bodies. The Royal Pharmaceutical Society has previously advocated for enhanced roles for pharmacists, but always with an emphasis on appropriate training, support, and governance. Opposition parties are expected to scrutinise the Government's plans for integrating these new roles, particularly concerning patient safety and the equitable distribution of healthcare resources.